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In recent years, technical developments in mouse genetics and imaging equipment have substantially
advanced our understanding of hematopoietic stem cells (HSCs) and their niche. The availability of numerous
Cre strains for targeting HSCs and microenvironmental cells provides extensive flexibility in experimental
design, but it can also pose significant challenges due to strain-specific differences in cell specificity. Here
we outline various genetic approaches for isolating, detecting, and ablating HSCs and niche components
and provide a guide for advantages and caveats to consider. We also discuss opportunities and limitations
presented by imaging technologies that allow investigation of HSC behavior in situ.Introduction
Hematopoietic stem cells (HSCs) in the adult human and mouse
predominantly reside in the bone marrow (BM), where blood cell
development occurs. The BM also contains nonhematopoietic
components such as bone-forming cells (including mesen-
chymal stem cells [MSCs] and osteoblast [Ob]-lineage cells),
adipocytes, vasculature, innervation from the sympathetic
nervous system, and other stromal cells such as adventitial retic-
ular cells, pericytes, and fibroblasts (Figure 1). It has long been
recognized that nonhematopoietic BM-derived stromal cells
are capable of supporting long-term hematopoiesis in vivo and
in vitro (Dexter et al., 1973, 1977; Schofield, 1978; Trentin,
1971; Wolf and Trentin, 1968). However, until recently little
was known about the anatomical location of HSCs within the
BM microenvironment (HSC niche), and the identities of the
HSC-supporting stromal cells were not well defined, limiting
our understanding of how HSCs are regulated.
Since the early 2000s there has been a significant improve-
ment in our understanding of the cell types that contribute to
the regulation of hematopoiesis and in particular HSCs (for
recent examples see Krause et al., 2013; Nakamura-Ishizu and
Suda, 2013). These advances have largely come from the devel-
opment of a broad range of genetically modified murine models
(both transgenic and targeted alleles) coupled with concurrent
innovation in imaging technologies. Here we review some of
the most commonly used transgenic strains of mice for detec-
tion/deletion studies in HSCs and microenvironment cell types
and highlight the advantages and limitations of these strains
where applicable. Our aim is to provide a useful guide for
designing and interpreting studies using the various strains
that are available. This review may help to explain why studies
investigating the effects of a given gene in a certain cell type
(e.g. HSC) can have different outcomes when different Cre
transgenic strains are used to target the cell. We also discuss
emerging imaging strategies for interrogating HSC behavior520 Cell Stem Cell 13, November 7, 2013 ª2013 Elsevier Inc.in situ and explain the benefits and caveats of different
approaches.
Genetically Modified Mouse Models Currently Used to
Study HSCs and Their Interactions with HSC Niches
Genetically modified mice have been widely applied to study
either HSCs or specific HSC niche cell types within the BM.
The ability to control the time and location of somatic mutations
in adult mice has allowed us to answer specific questions
regarding the roles of different cell populations in the regulation
of HSC homeostasis. These tools have been applied to deter-
mine the functional consequence of deleting single genes in
specific cell types (Table 1). Additionally the use of reporter
systems to illuminate a given cell lineage has enabled lineage-
tracking methods that allow prospective isolation and/or identi-
fication of a cell of interest. Note that there still remain limitations
to the interpretation of studies using these animal models. For
example, the inability to detect a phenotype in a cell-specific
conditional knockout mouse may not necessarily mean it has
no importance in the HSC niche because functional redundancy
can occur and/or other important factors may be produced by
that cell type to regulate HSCs.
Cre-Driven Transgenic Mice Commonly Used
to Identify HSCs
Myxovirus resistance-1 (Mx1-Cre). Mx1 is a vital part of the viral
defense mechanism and its expression can be highly induced
in response to interferon. Cre recombinase under the control of
the Mx1 promoter can be activated by mimicking viral infection
by the administration of synthetic double stranded RNA [poly(I):
poly(C)], an interferon-a/b (IFN) activator (Ku¨hn et al., 1995).
There is a low detectable rate of Cre induction generated by
endogenous interferon (Ku¨hn et al., 1995), and as a result pheno-
types have been observed in some strains in the absence of
pIpC treatment (Hartner et al., 2009; Isakoff et al., 2005). Further-
more, IFN itself influences HSC biology at levels much lower
Figure 1. The Complexity of HSC Niches
The major nonhematopoietic cell types in the BM
microenvironment that have roles in regulating
HSCs are shown. Genetically modified mouse
models that can target the cell types highlighted in
bold are discussed in this Protocol Review. Other
cell types (lightface) may also have roles in regu-
lating HSCs, but have not yet been explored in
detail using transgenic mouse strains, and hence
are not discussed here. Some cell types (e.g.
LepR+ and CAR cells) may be the same cell but
this has not yet been confirmed, so they are rep-
resented individually. Italicized words refer to tis-
sue structures within the BM. MSC, mesenchymal
stem cell; OP, osteoprogenitor; Ob, osteoblast;
Ocy, osteocyte; CAR, CXCL12-abundant reticular
cell; aSMA, a-smooth muscle cell actin-express-
ing cells; Nes+, nestin-positive cell; LepR+, leptin
receptor positive cell; EC, endothelial cell; SNS,
sympathetic nervous system.
Cell Stem Cell
Protocol Reviewthan that generated by pIpC used forMx1-Cre activation, which
may complicate the phenotype observed (Essers et al., 2009;
Hall et al., 2003; Hartner et al., 2009; Zhao et al., 2007).
Cell specificity. Mx1-Cre has been shown to be active in
several tissues including liver, kidney, and heart (Ku¨hn et al.,
1995). Mx1-Cre-targeted cells also include immature MSCs in
BM that were capable of forming Ob, chondrocyte, and adipo-
cyte lineages in vitro (Park et al., 2012). In vivo, however, Mx1-
CreYFP+ cells predominantly formedOb-lineage cells and rarely
adipocytes, with no Mx1-Cre YFP+ chondrocytes observed
(Park et al., 2012). Furthermore, Park et al. demonstrated that
more than 50% of nestin-positive cells in the BM were also
targeted byMx1-Cre, and thatMx1-Cre-GFP+ perivascular cells
were visualized close to the endosteum (Park et al., 2012).Mx1-
Cre did not target BM endothelial cells (ECs), skeletal muscle
cells, or fibroblasts in the BM of the mice.
Vav-Cre. Vav is a guanine nucleotide exchange factor regu-
lated by the Rho/Rac family of small G proteins (Lazer andCell Stem Cell 13,Katzav, 2011). The constitutively active
Vav-Cre mice have been commonly
used to achieve gene deletion in the he-
matopoietic system. Two Vav-Cre strains
have been generated, having only slightly
different specificity (Croker et al., 2004;
de Boer et al., 2003; Georgiades et al.,
2002). In one strain (Vav-Cre), the mice
were generated by the expression of
Cre under the control of the murine vav
gene regulatory elements (Croker et al.,
2004; de Boer et al., 2003; Georgiades
et al., 2002). In the other, the targeting
vector (Ogilvy et al., 1999) was modified
with the codon-improved Cre (iCre) cDNA
(which is less susceptible to epigenetic
silencing) (Shimshek et al., 2002) and
used to generate transgenic Vav-iCre
mice (Croker et al., 2004; de Boer et al.,
2003; Georgiades et al., 2002).
Cell specificity. Both Vav-Cre strains
have been shown to target hematopoieticcells and ECs, with Cre recombinase activity also reported either
in the testes in the Vav-iCre mice (Croker et al., 2004; de Boer
et al., 2003) or the ovaries in the Vav-Cre mice (Croker et al.,
2004; de Boer et al., 2003; Georgiades et al., 2002). This has
resulted in some offspring with germline deletion (A. Roberts,
personal communication). Both strains should always be bred
as heterozygous floxed mice with Cre+ males for the Vav-Cre
matings and Cre+ females for the Vav-iCre breeders to assist
in avoiding this issue.
Tie2-Cre. The Tie2 gene encodes a tyrosine kinase family
receptor specific to angiopoietin. Tie2 is expressed by ECs
and is important for angiogenesis (Maisonpierre et al., 1997;
Schnu¨rch and Risau, 1993). However, Tie2 is also expressed
by hematopoietic cells and plays a critical role in HSC quies-
cence (Arai et al., 2004; Takakura et al., 1998). Two strains of
transgenic mice expressing constitutively active Cre recom-
binase under the control of the Tie2 promoter were initially
generated to achieve endothelial-cell-specific deletion in vivoNovember 7, 2013 ª2013 Elsevier Inc. 521
Table 1. A Summary of HSC-Cre Mice, Their Advantages, and Their Limitations
Mouse Strain
Inducible/
Repressible Specific to HSCs?
Germline
Deletion?
Recommended Mating
Strategya
Other Potential Issues
Associated with this Strain
Mx1-Cre pIpC (IFN)
inducible
no: other cell types include
BM MSCs, nestin+ cells,
perivascular cells, and
cells in other tissues
no only one sex Cre+,
no preference
low levels of IFN present
normally in mice can induce
Cre recombinase activity
in some cells
Vav-Cre no no: also detects ECs
and cells in the ovaries
yes Cre+ male mated
to Cre female
none reported
Vav-iCre no no: also detects ECs
and cells in the testes
yes Cre+ female mated
to Cre male
none reported
Tie2-Cre* no yes: endothelial cells yes Cre+ male mated
to Cre female
none reported
HSC-SCL-
Cre-ERT
tamoxifen-
inducible
not when induced in
adult mice; however,
if given to embryos,
also detects ECs
no Only one sex Cre+,
no preference
none reported
pIpC, poly(I):poly(C); IFN, interferon; MSCs, mesenchymal stem cells; ECs, endothelial cells. (*) indicates information relevant to all strains generated.
aIt is very strongly recommended for all strains to use heterozygous breeders to generate age- and sex-matched littermate floxed/floxed (fl/fl) and
wild-type (WT) controls. Breeders consisting of a Cre and Cre+ pair are optimal for many strains because potential issues may arise if both mice
in the breeding pair are Cre+. For example, homozygosity in knockin Cre alleles disrupts expression of the endogenous gene generating a knockout
of that gene. Furthermore, it is highly recommended that groups of control mice that consisting of Cre fl/fl and Cre+ WT genotypes should be
investigated in studies determining the impact of gene deletion in a specific cell lineage to control for any impact that the floxed allele and the Cre
transgene may have on the cells and the animal, such as Cre toxicity (Turan et al., 2011). Potential effects of haploinsufficiency can be investigated
in the Cre+ floxed/+ mice. Germline deletion should be monitored in all strains that are susceptible to this off-target effect.
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roles in angiogenesis and hematopoiesis, Tie2-Cre mice display
Cre recombinase in both ECs and hematopoietic cells, espe-
cially HSCs (Constien et al., 2001; Tang et al., 2010). When
crossed to EGFP or eYFP reporter mice, both Tie2-Cre strains
were shown to have Cre expression in 80%–90% of the hema-
topoietic cells (Constien et al., 2001; Tang et al., 2010). No
differences appear to exist between specificity of these strains;
however, slight differences may arise based on where the
transgenes have integrated into the DNA of the mice.
While BM transplantation (BMT) studies can be performed
to test HSC potential, the deleted ECs may have altered the
potential of the HSCs prior to transplant; hence, any phenotype
observed may not be intrinsic to HSCs. Furthermore, it has been
shown that Sca-1+ lineage-negative BM cells contain trans-
plantable endothelial progenitor cells (Grant et al., 2002); thus,
the chimeras obtained upon transplantation have the potential
to contain some Tie2-Cre+ ECs in addition to HSCs. For these
reasons it is strongly advised that studies using Tie2-Cre mice
should investigate the potential contribution of both endothelial
and hematopoietic cells to the phenotype observed.
At least two other Tie2-Cre strains have been generated (Koni
et al., 2001; Theis et al., 2001), in addition to a Tie2-GFP strain
using the same construct (Motoike et al., 2000). All have shown
expression in ECs, but none of these have, to our knowledge,
been extensively investigated to determine whether there is
also expression in hematopoietic cells. However, given that
they used the same original vector that the other two strains
were slightly modified from (Schlaeger et al., 1997), they are
highly likely to show activity in hematopoietic cells.
Recently, two groups used different Tie2-Cre strains to show
that endothelial-derived CXCL12 is important in HSC mainte-
nance (Ding and Morrison, 2013; Greenbaum et al., 2013), with522 Cell Stem Cell 13, November 7, 2013 ª2013 Elsevier Inc.the Morrison lab using the Koni et al. strain (Koni et al., 2001)
and the Link lab using the Kisanuki et al. strain (Kisanuki et al.,
2001). Endothelial-cell-derived SCF was also shown to be
important in regulating HSCs by Ding et al. (2012) using the
Koni et al. strain (Koni et al., 2001).
Cell specificity. Investigators using Tie2-Cre mice should be
cautioned that progeny of Tie2-Cre mice can include offspring
with germline Cre expression (de Lange et al., 2008; Koni
et al., 2001). The Cre transgene has been shown to be trans-
mitted through the female germline, which can be avoided by
choosing Cre+ males to breed to Cre females (de Lange
et al., 2008; Koni et al., 2001).
HSC-SCL-Cre-ERT. The stem cell leukemia (Scl) gene is
known to play an indispensable role in both developmental
hematopoiesis and angiogenesis (Robb et al., 1995; Visvader
et al., 1998). Tissue-specific Scl expression is dictated by two
distinct regulatory elements: the 50 enhancer mainly driving the
endothelial Scl expression and the 30 enhancer mainly dedicated
to hematopoietic Scl expression (Go¨ttgens et al., 2002, 2004).
Capitalizing on this regulatory mechanism, Go¨thert et al. devel-
oped inducible tissue-specific Cre-recombinase-expressing
transgenic mice for hematopoietic cells (HSC-SCL-Cre-ERT)
(Go¨thert et al., 2005) and ECs (endothelial-SCL-Cre-ERT) (Go¨th-
ert et al., 2004). Tamoxifen-inducible Cre recombinase (Cre-ERT)
was developed by fusing a mutated estrogen receptor with the
Cre recombinase enzyme (Feil et al., 1996).
Cell specificity. Continuous administration of tamoxifen for
2 weeks (via chow) in HSC-SCL-Cre-ERT adult mice resulted in
Cre recombinase expression in 90% of long-term HSCs (identi-
fied as lineagec-Kit+Sca-1+Flt3) (Go¨thert et al., 2005). When
tamoxifen was administered prenatally (by feeding the mothers),
it was revealed that a population of embryonic-derived HSCs
persisted and repopulated hematopoiesis long-term in adult
Table 2. A Summary of Vascular/Perivascular Targeting Cre Mice, Their Advantages, and Their Limitations
Mouse Strain
Inducible/
Repressible
Specific to the Cell
of Interest?
Germline
Deletion?
Recommended
Mating Strategy
Other Potential
Issues Associated
with This Strain
Endothelial
cell strains
Tie2-Cre no no: HSCs also detected yes Cre+ male mated
to Cre female
none reported
VE-Cadherin-
Cre
no no: HSCs also detected no Only one sex Cre+,
no reported preference
none reported
VE-Cadherin-
CreERT2
tamoxifen-
inducible
not when induced in
adult mice; however,
if given to embryos,
also detects HSCs
no Only one sex Cre+,
no reported preference
postnatal induction
of Cre recombinase
activity does not
target all ECs
VE-Cadherin:
tTA-Cre
tetracycline-
inducible
has not been
investigated but
likely the same as
VE-Cadherin-CreERT2
no Only one sex Cre+,
no reported preference
has not been
investigated but
likely the same as
VE-Cadherin-
CreERT2
Cdh5(PAC)-
CreERT2
tamoxifen-
inducible
has not been
investigated but
likely the same as
VE-Cadherin-CreERT2
no Only one sex Cre+,
no reported preference
has not been
investigated but
likely the same as
VE-Cadherin-
CreERT2
MSC and
perivascular
Cre strains
Prx1-Cre no yes: although spine
cells are not detected
none
reported
Cre+ male mated
to Cre female
none reported
Prx1-CreER-
GFP
tamoxifen-
inducible
yes: although spine
cells are not detected
none
reported
Cre+ male mated
to Cre female
none reported
Nestin-Cre
(Tronche strain)
no no: central nervous
system, some other
cells in other organs
detected
yes Only one sex Cre+,
no reported preference
none reported
Nestin-Cre
(Trumpp strain)
no no: peripheral nerves,
ECs, gastroinstestinal
system, somites, some
other cells in other
organs detected
yes Cre+ male mated
to Cre female
Cre recombinase
activity reported
to be weaker when
inherited from Cre+
females
LepR-Cre no no: some brain cells
also detected
no Only one sex Cre+,
no reported preference
none reported
ECs, endothelial cells.
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SCL-Cre-ERT mice have relatively much lower Cre recombinase
expression outside the hematopoietic system and no reported
cases of germline Cre activation. However, when tamoxifen
was administered prenatally, Cre recombinase activity was de-
tected in ECs (Go¨thert et al., 2005). SomeECswere also targeted
by HSC-SCL-Cre-ERT when tamoxifen was administered to
adult mice, but at a much lower frequency than the proportion
of ECs targeted by endothelial-SCL-Cre-ERT (Go¨thert et al.,
2005). To date, our experience in using different HSC Cre strains
has suggested that HSC-SCL-Cre-ERT mice serve as the best
model for efficiently and specifically targeting adult hematopoi-
etic cells.
Different Cre Transgenic Mice Used to Detect HSC
Niche Cells: Vascular and Perivascular Cells
EC Cre Transgenic Mice
Aside from the Tie2-Cre mice discussed above, there are a
number of transgenic mice that can be used to detect and studyfunctions of ECs (Table 2). There is a common theme that, similar
to the EC targeting that occurs in many HSC ‘‘specific’’ strains, it
is virtually impossible to avoid some Cre recombinase activity in
hematopoietic cells when using EC promoters. This is likely due
to the embryonic origin of both definitive hematopoiesis and
endothelium, which arise from a shared precursor, the hemo-
genic endothelium (Hirschi, 2012). To try and minimize the con-
tribution of Cre+ hematopoietic cells, wild-type BM can be
transplanted into lethally irradiated EC-Cre strains; however,
small proportions of endogenous HSCs survive lethal irradiation
and can repopulate hematopoiesis in the transplanted mice,
meaning that Cre+ hematopoietic cells have the capacity to
contribute to the phenotype. Alternatively, Cre recombinase
activity in hematopoietic cells can be reduced by inducible Cre
recombinase activation in adult mice; however, this also is not
without complications, as discussed below.
VE-Cadherin. There are at least four published strains of
transgenic mice that target vascular endothelial (VE) cadherin
(also known as cadherin 5, or Cdh5). Two were generated inCell Stem Cell 13, November 7, 2013 ª2013 Elsevier Inc. 523
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Cadherin-Cre (Alva et al., 2006) and the tamoxifen-inducible
VE-Cadherin-CreERT2 (Monvoisin et al., 2006). Sun et al. (2005)
generated a tetracycline-regulated transcriptional activator
(tTA) under control of the VE-Cadherin promoter (VE-Cadherin:
tTA). The fourth strain [Cdh5(PAC)-CreERT2] was generated in
the Adams laboratory by the insertion of a tamoxifen-inducible
Cre into a large P1 artificial chromosome (PAC) clone of the
Cdh5 gene (So¨rensen et al., 2009). The constitutively active
VE-Cadherin-Cre and the Cdh5(PAC)-CreERT2 strains have
recently been used to show that endothelial-cell-derived Jag-
ged1 is an essential regulator of HSCs (Poulos et al., 2013).
Cell specificity. There is a lack of published information on the
specificity of the VE-Cadherin:tTA and Cdh5(PAC)-CreERT2
strains; however, the Iruela-Arispe laboratory has extensively
examined Cre recombinase activity in numerous organs in
embryonic and adult mice by lineage tracing, and it is likely
that this specificity is retained in the other VE-Cadherin strains.
In embryos, the majority of ECs in all organs showed Cre recom-
binase activity (Alva et al., 2006). However, significant propor-
tions of targeted hematopoietic cells were also observed in the
circulation, spleen, liver, thymus, and BM of E14.5 embryos. In
adult BM, approximately 50% of the cells showed Cre recombi-
nase activity in the constitutively active VE-Cadherin Cre strain
(Alva et al., 2006). A separate study by the same group used
flow cytometry (FACS) to demonstrate Cre recombinase activity
in all hematopoietic cell lineages (Zovein et al., 2008). Some
targeted cells were also detectable in the vessels of the thymus
and in the white pulp of the spleen in the constitutively active
VE-Cadherin Cre strain (Alva et al., 2006). It was unclear if these
were ECs or hematopoietic cells.
In the tamoxifen-inducible model, hematopoietic cells were
targeted when Cre was activated in embryos by injecting the
mothers with tamoxifen at E9.5. These were shown to arise
from the aortic-gonado-mesonephros (AGM) region (Zovein
et al., 2008). Very few hematopoietic cells showed Cre recombi-
nase activity when the Cre was activated postnatally (Monvoisin
et al., 2006).
Note, however, that the authors observed an inverse correla-
tion between the degree of excision and the age of the mice at
which tamoxifen was administered (Monvoisin et al., 2006). It
appears that inducing Cre recombinase in postnatal pups is
preferred when aiming to reduce the extent of hematopoietic
excision but that Cre recombinase activity in postnatally excised
ECs may not be optimal, especially if using the inducible VE-
Cadherin Cre strains to excise in older (6- to 8-week-old) mice.
Similar issues with detection have also been observed with the
endothelial-SCL-Cre-ERT strain (Go¨thert et al., 2004); hence, it
is possible that this also applies to other inducible EC strains.
MSCs and Perivascular Cre Strains
Prx1-Cre. Prx1 (also known as MHox) is a paired family homeo-
box gene expressed early during limb bud mesenchyme devel-
opment (Martin et al., 1995). Prx1-Cre mice were recently used
to achieve targeted deletion of chemokine (C-X-C motif) ligand
12 (CXCL12) in immature mesenchymal stem/progenitor cells.
The resulting mobilization and depletion of HSCs in the BM
demonstrated that these Prx1-Cre-expressing cells are an inte-
gral part of the HSC niche (Ding andMorrison, 2013; Greenbaum
et al., 2013). Previous elegant studies by Sugiyama et al. used a524 Cell Stem Cell 13, November 7, 2013 ª2013 Elsevier Inc.CXCL12-GFP reporter mouse to describe the presence of
CXCL12-abundant reticular (CAR) cells in the BM that had
important roles in regulating HSC quiescence (Sugiyama et al.,
2006). Greenbaum et al. (2013) recently demonstrated the exis-
tence of a small population of cells targeted by Prx1-Cre that
coexpressed CXCL12-GFP and exhibited properties consistent
with MSCs.
Cell specificity. Prx1-Cre transgenic mice display varied levels
of germline deletion when the Cre transgene is transmitted
through female heterozygous mice (Logan et al., 2002). Further-
more, the spine, which is of lumbar origin (Logan et al., 2002), is
not targeted by Prx1-Cre, suggesting that Prx1-Cre cells do not
give rise to all bone-forming cells in the body.
Nestin-Cre (Nes-Cre). Nestin is a type IV intermediate filament
initially identified with a neuroepithelial-stem-cell-restrictive
expression in the brain (Lendahl et al., 1990). However, nestin
expression has been reported in a range of distinct brain- and
tissue-specific progenitor cells (Wiese et al., 2004). Nestin
expression by muscle or neural progenitors has been shown to
be regulated by cell-specific regulatory elements in the first
and second intronic region, respectively, of the rat nestin gene
(Zimmerman et al., 1994). Using this knowledge, two different
constitutively active Nes-Cre transgenic strains were generated
using the 5.8 kb rat nestin promoter and intron 2 enhancer to
drive Cre recombinase expression (Tronche et al., 1999; Trumpp
et al., 1999). Both showed extensive recombination in the central
nervous system (CNS) but also have many off-target effects as
discussed below.
Recent studies from the Frenette laboratory used Nes-GFP
reporter mice (Mignone et al., 2004), whichwere generated using
similar constructs to the Nes-Cre strains, to identify perivascular
nestin-expressing cells in the BMwith in vitro MSC potential that
contributed to the regulation of HSCs (Me´ndez-Ferrer et al.,
2010). The Morrison lab used the Nes-Cre strain generated by
Tronche et al. to show that deletion of CXCL12 from nestin-
expressing cells had no impact on HSCs or hematopoiesis
(Ding and Morrison, 2013). This is in contrast to the profound
effects observed on HSCs when Prx1-Cre was used to delete
CXCL12 in MSCs (Ding and Morrison, 2013; Greenbaum et al.,
2013); hence, it is unlikely that Nes-Cre-targeted cells are
the same cell as Prx1-Cre-targeted cells. It is possible that the
Nes-GFP mice identify different cells to those reported by the
Nes-Cre strains; however, this currently remains undetermined.
Cell specificity. The Nes-Cre transgenic strain developed by
Tronche et al. has been reported to have Cre recombinase
activity in tissues outside the brain including the kidney, retina,
and heart (Martins et al., 2008; Tronche et al., 1999). Further-
more, the Nes-Cre transgenic mice developed by Trumpp
et al. exhibited Cre recombinase activity in kidney, peripheral
nerves, ECs, the gastrointestinal system, and somite tissues
(Dubois et al., 2006). In addition, the Cre recombinase activity
was weaker in the offspring when inherited thorough a female
Cre+ parent (Dubois et al., 2006). Furthermore, despite studies
from the Frenette lab showing MSC potential in vitro, very few
cells giving rise to mesenchymal-derived lineages (chondro-
cytes, bone, and fat) were observed in the bones of the mice
in vivo when the Tronche Nes-Cre mice were crossed to the
R26R (LacZ) strain (Me´ndez-Ferrer et al., 2010); hence, further
clarification of the nature of the BM-derived nestin-positive cells
Table 3. A Summary of Osteoblast-Cre Mice, Their Advantages, and Their Limitations
Mouse Strain
Inducible/
Repressible
Specific to the
Cell of Interest?
Germline
Deletion?
Recommended
Mating Strategy
Other Potential
Issues Associated
with This Strain
Osteoprogenitors
(OPs)
Osx1-GFP::Cre doxycycline-
repressible
yes: but may
not detect all
Ob-lineage cells
no Cre+ male mated
to Cre– female
growth retardation
(Davey et al., 2012)
and malocclusion
occur often in Cre+
mice including
wild-types
Osx-CreERT2 tamoxifen-
inducible
yes: but may
not detect all
Ob-lineage cells
no Only one sex Cre+,
no preference
none reported
Mature osteoblasts
(Obs)
Mouse Col2.3-Cre no yes no Only one sex Cre+,
no reported
preference
none reported
Rat Col2.3-Cre no no: some expression
in articular cartilage,
occasional activity
in growth plate
chondrocytes
yes Cre+ male mated
to Cre– female
none reported
Rat Col3.6-Cre no no: also present in
tendon, fascia
fibroblasts; some
expression in articular
cartilage, occasional
activity in growth plate
chondrocytes
yes Cre+ male mated
to Cre– female
none reported
Osteocytes (Ocys) Dmp1-Cre (8 kb) no no: present in some
brain cells
no Only one sex Cre+,
no reported
preference
none reported
Dmp1-Cre (9.6 kb) no no: present in Obs,
muscle, intestines,
and brain
no Only one sex Cre+,
no reported
preference
none reported
Ob, osteoblast.
Cell Stem Cell
Protocol Reviewis required. More importantly, both of the Nes-Cre lines display
germline activation (Dworkin et al., 2009). Inducible Nes-Cre
transgenic strains generated using similar constructs are avail-
able (Balordi and Fishell, 2007; Chen et al., 2009), and hence
may overcome this latter issue.
Leptin Receptor-Cre (LepR-Cre). Leptin is an adipocyte
secreted circulating hormone that acts through the leptin recep-
tor (LepR) to regulate energy metabolism in the body. Recently,
using the stem cell factor (Scf)gfp knockin mice, Ding et al. (2012)
determined that Scfgfp-expressing BM perivascular stromal
cells expressed LepR. Furthermore, LepR-Cre-based deletion
of SCF negatively affected HSC maintenance in the BM. These
cells were identified to be distinct from the Nes-Cre targeted
perivascular BM stromal cells (Ding et al., 2012). However, a
recent study using LepR-Cre-tdTomato reporter mice crossed
to Nesgfp mice showed that the majority of LepR-targeted cells
express nestin (Pinho et al., 2013). Further studies are warranted
to conclusively determine the nature of these cells.
Cell specificity. The LepR-Cre mice have been reported to be
brain specific (Plum et al., 2007; Scott et al., 2009); however, the
lineage tracing studies have not been extensive to date and have
omitted studies in hematopoietic organs. Given the phenotype
observed by Ding et al. (2012), a more comprehensive lineagetracing study is warranted to identify the BM-containing LepR-
positive cells.
Ob-Lineage Cre Mice
The bone cavity and BM in which hematopoiesis occurs contain
a range of Ob-lineage cells, differentiating from immature
mesenchymal/skeletal stem cells (discussed above) to osteo-
progenitors (OPs) to mature bone-forming Obs and ultimately
osteocytes (Ocys) embedded in the bone matrix (Askmyr et al.,
2009). The strains that have been most commonly used to
show distinct roles for differently staged Ob-lineage cells in
hematopoiesis are discussed below (Table 3), and others have
also been overviewed by Elefteriou and Yang (2011).
Osx1-Cre (OPs). Osterix (Osx) is a zinc-finger-containing
transcription factor, essential for Ob differentiation and bone
formation (Nakashima et al., 2002). Osx expression is switched
on at the OP stage of osteogenic differentiation, downstream
of the transcription factor Runx2. Osx1-GFP::Cre transgenic
micewere generated by pronuclear injection of a BAC containing
the mouse Sp7 gene (encoding Osx) targeted at exon 1 (Rodda
and McMahon, 2006). In these mice a tetracycline (Tet)-off
controlled GFP::Cre fusion protein is under the transcriptional
control of the Sp7/Osx1 promoter, allowing repression of Cre
recombinase by administration of doxycycline (Rodda andCell Stem Cell 13, November 7, 2013 ª2013 Elsevier Inc. 525
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separately generated, by BAC methods, tamoxifen-inducible
Osx-CreERT2 mice in which CreERT2 is under the control of the
Osx gene promoter.
Studies using the Osx1-GFP::Cre mice have been used to
show that deletion of the heterotrimeric G protein a subunit
(Gsa) or components of the HIF signaling pathway inOsx1+ cells
impaired B cell lymphopoiesis (Wu et al., 2008) or erythropoiesis
(Rankin et al., 2012), respectively. Furthermore, deletion of
CXCL12 in Osx1-GFP::Cre mice resulted in hematopoietic
progenitor cell (HPC) mobilization and a loss of B lymphoid
progenitors but did not affect HSCs (Greenbaum et al., 2013).
Cell specificity. Lineage tracing studies in embryos, neonates,
and adult mice using either strains have shown that Osx1-Cre
targets Ob-lineage cells in the perichondrium/periosteum, within
the trabecular and cortical bone regions and in the skull bones
(Maes et al., 2010; Rankin et al., 2012; Rodda and McMahon,
2006). Stromal cells inside the developing bone (considered to
be immature OPs) also expressed Cre recombinase, as did the
mature Ocys. There was also some Cre recombinase activity
detected in the lower zone of columnar chondrocytes and in pre-
hypertrophic chondrocytes, consistent with known expression
of Osx in these cell types (Maes et al., 2010; Rankin et al.,
2012; Rodda and McMahon, 2006). Interestingly, a subset of
Osx+ cells in either strain was noted to be perivascular in embry-
onic and adult mice, and these are considered to be OPs
migrating to the bone during development and repair after injury
(Maes et al., 2010).
Col1a1-Cre (mature Obs). Two different mouse strains of the
Col2.3-Cre mice have been made using either the mouse
Col2.3 promoter (Dacquin et al., 2002) or the rat Col2.3 promoter
(Liu et al., 2004) to drive Cre recombinase. In each of these
strains, the Col2.3 promoter efficiently targeted all mature Obs
in the body and virtually no Cre recombinase activity was
observed in other tissues (Dacquin et al., 2002; Liu et al.,
2004). Transgenic mice generated using the rat 3.6 kb Col1a1
promoter exhibit Cre recombinase expression in early Obs, peri-
chondrium, and suture mesenchyme (Liu et al., 2004). In addi-
tion, both the 2.3 kb Col1a1-Cre and 3.6kb Col1a1-Cre mice
generated using the rat promoters displayed Cre recombinase
activity in articular cartilage, with occasional activity detected
in growth plate chondrocytes (Liu et al., 2004).
The mouse promoter-derived Col2.3-Cre mice have been
used to demonstrate important roles for osteoblastic connexin
43 in regulating HSCs (Gonzalez-Nieto et al., 2012) and to
show that mature Obs do not regulate HSCs via N-cadherin
(Bromberg et al., 2012; Gonzalez-Nieto et al., 2012). Ding et al.
used the rat Col2.3-Cre mice to show that deletion of CXCL12
(Ding andMorrison, 2013) or SCF (Ding et al., 2012) in Ob-lineage
cells did not impair HSC function. BM from the Col2.3-Cre-
Cxcl12flflmice was, however, reported to have impaired lympho-
poiesis when transplanted into wild-type recipient mice (Ding
and Morrison, 2013). Furthermore, Col2.3:GFP mice, which
were generated using the same rat reporter as the Col2.3-Cre
mice (Dacic et al., 2001), were used to show that HSCs localize
adjacent to GFP+ Obs at early time points after transplantation
(Lo Celso et al., 2009).
Cell specificity. Another constitutively active Cre strain
generated using the rat 2.3 kb Col1a1 promoter targeted rare526 Cell Stem Cell 13, November 7, 2013 ª2013 Elsevier Inc.CD45+ fibrocyte-like cells in BM (Ohishi et al., 2012); hence,
this may also apply to the other rat 2.3 kb Col1a1-Cre mice.
Furthermore, theCol1a1-Cre transgenic mice employing rat pro-
moters have reported cases of germline activation transmitted
at a higher incidence through females (Cochrane et al., 2007;
Liu et al., 2004; Scheller et al., 2010). It has also been reported
in 3.6 kb Col1a1-Cre-p53fl/fl mice that approximately 20% of
mice develop lymphoma (Lengner et al., 2006). While it is
possible that changes in the microenvironment could contribute
to the lymphoma, lineage tracing studies are required to show
that hematopoietic cells are not targeted by 3.6 kb Col1a1-Cre.
Dmp1-Cre (Ocys). Dentin matrix acidic phosphoprotein
(Dmp1) is an extracellular matrix protein expressed highly in
mineralized tissue such as that by Ocys in bone and by odonto-
blasts in teeth (Feng et al., 2003). Transgenic mice generated
using the 8 kb promoter region of Dmp1 to drive GFP expression
found its expression restricted to osteocytic cells of the bone
lineage, odontoblast, and a few brain cells (Kalajzic et al.,
2004). Furthermore, Lu et al. (2007) generated Dmp1-Cre trans-
genic mice by placing Cre recombinase under the control of a
9.6 kb Dmp1 promoter. These Dmp1-Cre mice displayed Cre
recombinase activity in Ocys, odontoblasts, and a few Obs.
They were recently used to demonstrate defective myelopoiesis
in mice bearing Ocy-specific deletion of Gsa (Fulzele et al.,
2013).
Cell specificity. The 9.6 kbDmp1-Cre strain has been reported
to have off-target activity in Obs, muscle, intestine, and brain
(Xiao et al., 2011; Xiong et al., 2011). Recently generated 8 kb
Dmp1-Cre have shown increased specificity to Ocys with no
reported Cre recombinase activity in Obs (Bivi et al., 2012) and
may provide better insight into the contribution of Ocys to the
regulation of hematopoiesis.
Reporter Mice Used to Detect or Ablate HSCs
or HSC Niche Cells
The use of lineage tracing has been a significant advance in the
application of genetically engineered mouse models to under-
stand HSCs and the BM microenvironment (Blanpain, 2013;
Blanpain and Simons, 2013; Fuchs and Horsley, 2011). The
permanent identification of the cells generated from the Cre
of interest allows identification of these cells and can also pro-
vide important information regarding the specificity of the Cre
line for the proposed target population. These reporters serve
several purposes and can be applied for multiple reasons. First,
they permit the identification and isolation of cells in which Cre
has been activated and also permit analysis of the specificity
of a given Cre for a lineage. A major caveat is that the activated
reporters mark all progeny of cells in which Cre has been
expressed. For example, if Cre is expressed in an HSC, the
reporter’s expression will be detected in all hematopoietic cells
that come from that HSC. The expression of Cre developmen-
tally may be different from that in the adult and, as mentioned
above for EC Cre strains, constitutive Cre lines can lead to the
presence of labeled cells where they would not have been ex-
pected as a result of these developmental differences.
The use of lineage reporters allows visualization of the cells
that are contributing to a phenotype and their ready isolation,
in most cases by flow cytometry. An alternative use of these lines
is to allow pulse chase analysis of the life span of a population
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ible Cre lines exist for the cell populations of interest. The rate
at which a population loses the induced mark can be used to
determine the rate of turnover of that population in vivo.
Until recently, most reporter systems were a binary model of
off and on with the expression of a fluorophore, most commonly
GFP or derivatives. New, more sophisticated models have been
developed that allow for clonal analysis and color substitutions.
Rosa26 Strains
One of themost widely used reporter models incorporates a loxP
flanked stop cassette into the Rosa26 (R26) locus (Soriano,
1999). The R26 strain shows ubiquitous expression in embryos
and adult tissues (Soriano et al., 1991; Zambrowicz et al.,
1997). Furthermore, homozygous R26 mice are viable, making
it possible to breed two different strains of R26 mice (e.g. a de-
leter and a reporter strain) together for experimental purposes.
When used in reporter strains, after Cre exposure the stop
cassette is removed and expression of the reporter construct
is initiated. These models have been used with a range of
reporters including LacZ, GFP, and eYFP (Mao et al., 1999;
Srinivas et al., 2001). The R26 strains have been widely used
for many studies and there are many variations on this approach
incorporating alternative loci, more highly expressed promoters,
or multiple fluorophores, which allow tracing of cells exposed to
Cre (e.g. membrane-targeted GFP, mG) and an alternate label
(membrane-targeted tandem dimer tomato, mT) for unexposed
cells (Madisen et al., 2010; Muzumdar et al., 2007). At present
the Jackson laboratory repository offers hundreds of different
variations of R26 fluorescently labeled or LacZ-expressing
strains. It has been observed, however, that there can be varie-
gated expression of the Rosa26 locus, the impact of which
needs to be assessed in each application (Hameyer et al., 2007).
Multicolored Reporter Mice
A variation on the binary reporter systems has been the develop-
ment of multicolored reporters that rearrange following Cre acti-
vation andmark a clonal population with one of four or more fluo-
rophores. These mice include the ‘‘Brainbow’’ mice (restricted
to brain studies due to the nature of the reporter), which gener-
ates at least 90 colors (Livet et al., 2007), and the ‘‘Confetti’’
mice, which form four different fluorophores that can be detected
by FACS and in tissue sections (Snippert et al., 2010).
The multicolored approaches permitted by the Brainbow and
Confetti reporters have been revelatory in understanding the
clonal contribution of stem cells, especially when coupled with
inducible Cre models where a temporal exposure to ligand re-
sults in Cre activity for a short period of time. This experimental
approach leads to the generation of clonally identifiable stem
cell populations whose behavior and contribution to organ ho-
meostasis can be measured. The Confetti reporter mice have
recently been used to identify hemospheres consisting of ECs,
mesenchymal cells, and hematopoietic cells that support HSC
clonal expansion (Wang et al., 2013). When combined with
advanced imaging and analysis, these powerful reporter strains
can reveal new biology about the in vivo relationship of distinct
cell populations.
Conditional Ablation of Cell Lineages: Thymidine-
Kinase- or Diptheria-Toxin-Expressing Mice
The two previously discussed reporter mouse approaches utilize
Cre to mark cells with one or more tracers to allow further anal-ysis. An alternative is to specifically remove a cell population
and then assess the consequences of this on homeostasis of
the organ. This is made possible by generatingmice that express
either a truncated form of the herpes simplex virus-thymidine
kinase (HSV-tk) gene (Visnjic et al., 2001) or the diptheria toxin
receptor (DTR), under the control of the promoter gene of the
cell type of interest (Brockschnieder et al., 2004; Saito et al.,
2001). Injection of the resulting mice with either ganciclovir or
diptheria toxin, respectively, results in selective ablation of the
targeted cell.
The HSV-tk enzyme is not toxic to the mammalian system.
However, HSV-tk phosphorylates specific nucleoside analogs
(such as ganciclovir or acyclovir) to the nucleoside monophos-
phate. This, in turn, is phosphorylated into the nucleoside
triphosphate and incorporated into DNA, inhibiting DNA synthe-
sis and hence resulting in cell death in the cell type expressing
HSV-tk, but leaving the other cell types unharmed (Heyman
et al., 1989). The tk gene causes sterility problems in transgenic
males, but this can be overcome using a truncated, functional
form of the enzyme (Dtk). Visnjic et al. (2001) achieved Ob-spe-
cific ablation using rat Col2.3Dtk mice injected with ganciclovir,
demonstrating that ablation of Obs resulted in numerous he-
matopoietic defects, including mobilization of HSCs (Visnjic
et al., 2004).
The DTR is not naturally expressed by mice (Cha et al., 2003),
allowing for cell-specific loss of viability by engineering mice to
express DTR in the desired cell of interest. Cell deletion can be
achieved by injecting the mice with diptheria toxin. Me´ndez-Fer-
rer et al. (2010) used this approach to deplete nestin+ cells in
mice, showing that HSCs were mobilized from the BM but that
other hematopoietic cell types were not affected. Furthermore,
Asada et al. (2013) used Dmp1-DTR mice to demonstrate that
ablation of Ocys resulted in failure of mobilization of HSCs and
progenitor cells in response to G-CSF.
Additional Methods Used to Detect HSCs:
Label Retention
In addition to the use of reporter mice for HSC studies, other
methods can be used to label HSCs based on their quiescence.
HSCs, as is the case with many other somatic stem cells, have
long been known to be quiescent, especially when compared
to the highly proliferative HPCs they give rise to. Genetic or
chemical labeling of quiescent cells based on initial uniform label
(pulse), followed by label dilution during cell division events
(chase), has therefore proven useful to identify a subpopulation
of HSCs that are particularly quiescent (or dormant), have the
highest reconstitution potential, and respond to specific injuries
by proliferating and giving rise to differentiating progeny. Pio-
neering studies by Bradford et al. (1997) used continuous oral
bromodeoxyuridine (BrdU) administration (which incorporates
into the DNA of dividing cells) to demonstrate that the most
primitive HSCs cycle slowly, with an average turnover time of
30 days, and to show that there is a hierarchy of HSCs based
on quiescent properties. An additional study by Wilson et al.
(2008) identified label-retaining HSCs (LRCs) by two methods
in parallel: BrdU administration and doxycycline-regulated
expression of the fusion protein histone 2B-GFP (H2B-GFP),
which had been generated to identify label-retaining cells in
the epidermis (Tumbar et al., 2004). While BrdU detectionCell Stem Cell 13, November 7, 2013 ª2013 Elsevier Inc. 527
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allows FACS-based purification, transcriptional profiling, and
functional testing of LRCs.
Caution must be taken with the administration of BrdU. If
injected into the animal, BrdU will only be incorporated into the
DNA of cells that are dividing at the time of injection. Hence
the cells that do not contain BrdU after a short period of admin-
istration of BrdU are not necessarily HSCs. The best way of
administering BrdU to ensure HSC labeling is by adding it to
the drinking water of the mice in bottles that are protected
from light for extended periods of time.
There are also experimental limitations of BrdU studies. There
are concerns that the BrdU method may not sufficiently detect
all HSCs (Kiel et al., 2007). Furthermore, BrdU has been shown
to lead to activation of dormant HSCs and therefore to inherently
alter the physiology of the tissue (Wilson et al., 2008). Regardless
of these issues, label retention studies combined with immu-
nofluorescence techniques permitted the identification of
dormant HSCs and suggested that different types of HSCs
reside in specific niches that may be composed of unique com-
binations of cell types, most likely located in specific BM areas.
Emerging Technologies to Visualize HSC Interactions
with Their Niches
Confocal Laser Scanning Microscopy
Several groups have used a variety of approaches to genetically
or chemically label HSPCs (recently reviewed in Progatzky et al.,
2013), transplant them, and study their homing within the BM
space of recipient mice by means of histological analysis of
tissue sections. Functional, engrafting HSCs are only observed
in myeloablated recipients; however, the irradiation procedures
alter important cell types that contribute to the niches, including
ECs (Hooper et al., 2009) and Obs (Dominici et al., 2009), hence
presenting a limitation to the knowledge obtained using trans-
planted HSCs. The development of the SLAMmarkers signature,
allowing identification of HSCs based on staining with a limited
number of antibodies, led to the first analysis of HSC localization
in nonperturbed BM sections using confocal laser scanning
microscopy (CLSM) (Kiel et al., 2005), and histological studies
of BM sections are currently very popular. These localization
studies are, however, not without their limitations: the complexity
of the HSC niche is not fully captured by 2D sections. This can be
partly overcome by performing serial sectioning, which however
remains challenging and, due to restrictions in section thickness
and width, might not be able to capture all interactions of the
HSC with surrounding microenvironment cells. Furthermore,
CLSM studies are not performed in real time with living cells,
and dynamic interactions cannot be captured by single time-
point analysis.
Intravital Microscopy
Intravital microscopy solved all these initial limitations and has
been used to observe the behavior of HSPCs in real time in
multiple bone areas. Epifluorescence microscopy was used to
pioneer imaging in the BM contained within themouse skull fron-
tal bones (Mazo et al., 1998), and higher resolution images were
obtained using confocal (Sipkins et al., 2005) and combined
confocal and two-photon microscopy (Lo Celso et al., 2009;
Sipkins et al., 2005). In particular, the combination of confocal
and two-photon microscopy allows expanding the palette of528 Cell Stem Cell 13, November 7, 2013 ª2013 Elsevier Inc.analyzable labels to span from bone collagen second harmonic
generation signal to near-infrared Quantum dots such as
Qdot800, permitting the monitoring of multiple components of
the HSC niche simultaneously (Lo Celso et al., 2011). HSCs
localized in femur and tibia BM have been observed by intravital
microscopy following insertion of an endoscopic probe from
the knee (Lewandowski et al., 2010) and exposure and surgical
thinning of the compact bone (Ko¨hler et al., 2009), respectively.
Both of these approaches are effective; however, they are highly
invasive and therefore allow only a single imaging session to be
performed. Imaging has also been successfully performed to
detect the homing of HSCs in halved femurs at early time points
posttransplantation; however, this required euthanasia of the
animal prior to ex vivo imaging of the sample (Xie et al., 2009).
Instead, calvarium imaging is minimally invasive, and even
though it is restricted to observing a relatively small proportion
of exclusively narrow BM cavities, it is the only imaging modality
to date that permits the investigator to monitor HSCs for longer
periods of time over multiple imaging sessions (Lo Celso et al.,
2009).
Since HSC-specific reporter transgenic lines are not currently
available, all intravital imaging approaches are based on trans-
plantation models, requiring myeloablative conditioning of
the recipients. These studies have therefore been providing
insights on HSC-niche interactions during early engraftment,
at a time in which both HSCs and the BM microenvironment
are exposed to very high levels of stress. The use of engraft-
ment-permissive lines such as W/Wv mice (Migliaccio et al.,
1999) avoids the need for harsh conditioning methods, but still
has the limitation that the microenvironment observed is not
wild-type. The development of new reporter strategies is
greatly needed to obtain imaging of HSCs in situ, in physiolog-
ical conditions.
Laser Scanning Cytometry
Another, more recently developed technology is becoming pop-
ular in studies for imaging HSCs: laser scanning cytometry
(termed LaSC here so as not to confuse with leukemia stem
cells). Unlike intravital microscopy studies, LaSC does not
require transplantation of HSCs into perturbed microenviron-
ments, permitting in situ analysis. While limited in that they
cannot perform live-cell imaging, the noninvasive studies made
possible by both LaSC and CLSM provide complementary and
alternative methods for studying HSC-niche interactions.
The LaSC is an automated, cellular analyzer that combines the
imaging resolution of CLSM with the quantitative capabilities of
FACS (Henriksen et al., 2011). The union of these technologies
permits the LaSC to measure multiple fluorescently labeled cells
on adherent specimens including tissue samples/biopsies,
cytology smears, and cultured cells (Ta´rnok and Gerstner,
2002). The advantage of preserving tissue architecture is that it
allows the acquisition of morphological and subcellular compo-
nents of individual cells in their natural microenvironment. The
LaSC additionally records the precise spatial coordinates of a
molecule or cell within the section and permits the construction
of detailed tissue maps. This feature also makes it possible for
researchers to study molecular and cellular events and inter-
actions in situ, a platform that has not been available before
(Harnett, 2007; Nombela-Arrieta et al., 2013; Oswald et al.,
2004; Zhao et al., 2010).
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carded postacquisition and can therefore be restained and rean-
alyzed, a feature that may be invaluable for research and clinical
samples that have very little cells, in particular samples obtained
from fine-needle aspiration biopsies. Several clinical studies
have reported the successful use of the LaSC for the immuno-
phenotyping of hematological specimens (Clatch et al., 1996,
1998), for measuring DNA content (Clatch and Foreman, 1998;
Wojcik et al., 2001; Zabaglo et al., 2003), and for tissue histology
(Gerstner et al., 2004). Results from these studies were com-
parable to conventional immunocytochemistry analyses, with
advantages for certain applications including the ability to corre-
late individual cell morphology to fluorescence data, reduced
specimen and reagent use, exclusion of pathologist interpreta-
tions, simplified methodologies, and high reproducibility.
LaSC technology is distinct from CLSM in that it collimates the
laser beam (i.e. makes the beam as parallel as possible) to allow
all the emitted light to be quantified from the entire depth of the
cell. This increases both the depth of field (typically 20 to 30 mm)
and the area that can be scanned in focus, thereby allowing
automated analysis possible on relatively large sections of tis-
sue. In contrast, CLSM analyses light emitted near the focal
plane to provide excellent spatial resolution in a small optical
area, but this also permits serial optical sectioning of samples
and their reconstruction into 3D images. Due to these differ-
ences, LaSC can be elegantly complemented by CLSM, as
recently exemplified by a study by Nombela-Arrieta et al.
(2013). This study adapted the use of the LaSC to quantify the
distribution of three defined populations of hematopoietic stem
and progenitor cells (HSPCs) within whole BM tissue sections.
After showing that HSPCs preferentially localized in endosteal
regions of bone, closer to blood vessels, they further confirmed
their findings with detailed 3D reconstructions of BM microvas-
culature using CLSM.
Whole-Mount Imaging and Computational Modeling
Methods
The employment of new quantitative imaging technologies will
help us to define key factors involved in the regulation of HSCs
in their microenvironment. In support of this, recent develop-
ments using whole-mount confocal immunofluorescence imag-
ing techniques combined with computational modeling have
been optimized to obtain the first 3D reconstructions of the BM
within the bone cavity in its entirety (Kunisaki et al., 2013). This
revealed that small arterioles ensheathed by pericytes that
coexpressed nestin, a-smooth muscle cell actin, and the glial
marker NG2 have critical roles in regulating quiescent HSCs
(Kunisaki et al., 2013).
Concluding Remarks
In conclusion, a range of valuable genetically modified mouse
strains, combinedwith reporters and advanced imaging technol-
ogies, have begun to help unravel important regulatory mecha-
nisms of HSC niches. While these have brought great advances
to our understanding of how HSCs are regulated by their micro-
environments, there is a clear need to improve our understand-
ing of HSC-niche interactions and to convert these data into
biologically and clinically informative results. Studies using
human biopsies are likely to become more commonplace for
HSC-niche interaction studies with the increasing use of tech-nologies such as laser scanning cytometry (Henriksen et al.,
2011) and laser confocal microscopy studies (Takaku et al.,
2010). While we still have far to go, HSC niche research is
increasingly evolving and highly exciting.ACKNOWLEDGMENTS
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